Fortress Biotech, Inc. (NASDAQ: FBIO) is a Healthcare company (Biotechnology) with a market capitalization of $61M. The Maz Rating grades it against the other companies in its sector.
Fortress Biotech, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.82, Fortress Biotech, Inc. trades at 0.6x trailing earnings, 0.9x sales and 0.4x book value. Over the last twelve months it generated about $70M of revenue and $97M of net income. It runs a gross margin of 63.2%, an operating margin of -42.5% and a net margin of 143.0%. It shows return on equity of 74.7%, return on invested capital of -13.1% and a free cash flow yield of 206.6%. On the balance sheet: a debt-to-equity ratio of 0.24 and a current ratio of 2.93. Over the past 52 weeks the share price ranged from $1.64 to $4.53, with a beta of 1.25.
Fortress Biotech, Inc. does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 6 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.